Decoding Precision Medicine In Prediabetes: A Citespace-Based Bibliometric Analysis Of Current Trends And Future Directions

This study highlights the growing role of precision medicine in prediabetes research, focusing on risk stratification, biomarker-guided subtyping, and individualized interventions. Analyzing 103 publications, it identifies a shift in research from traditional metabolic risk factors to insulin resistance, genetic biomarkers, and AI-assisted patient stratification. The USA leads in research output, with Harvard Medical School and the University of Copenhagen as key institutions. The study underscores the importance of integrating multi-omics technologies, continuous glucose monitoring, and AI into precision prevention frameworks, aiming for early diagnosis and personalized treatment strategies in prediabetes.